A nine-institution team led by Carnegie Mellon University (CMU), and including the Children’s Hospital of Philadelphia (CHOP), has secured an award of up to $39.3 million from the Advanced Research ...

Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid therapy approach, today announced that the last patient has completed their last visit (LPLV) in the ...

Medical program uses a 2 ATA hardshell chamber with individualized screening, treatment planning and ongoing clinical ...

Justin Balko, PharmD, PhD, explains why residual disease in triple-negative breast cancer signals a biology gap, and what ADC trials and cell-free DNA monitoring may reveal. Patients with stage 2 and ...

Gene and cell therapies are reshaping the treatment landscape for inherited, degenerative, and acquired disorders. Yet successful translation depends on ...

Use of automated insulin delivery technology improves a Healthcare Effectiveness Data and Information Set quality measure in ...

INTERBED connectivity transformed existing bedside monitors into a centralised critical care surveillance system, demonstrating a cost neutral approach that could improve patient monitoring in ...

Most patients with heart failure, cardiometabolic disease, or multimorbidity are still managed through standardised pathways ...

Five NHS trusts are being offered fully funded support to assess the safety and performance of AVT through a new pilot.

Study published by Lancet Regional Health helps doctors manage new class of drugs for kidney transplant patients suffering organ rejection Serial monitoring of patients through donor-derived cell-free ...

This story is part of your SHN+ subscription Senior living providers are incorporating more mental and behavioral health ...

My approach to diabetes care has long been rooted in biomedical models focused on numbers: A1c, fasting glucose and ...